Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
HIHillstream BioPharma, Inc. logo

Hillstream BioPharma, Inc. (HILS)

NASDAQ Capital Market · Currency in USD
$0.24 ▲ +0.01 (+5.66%)
At close: Sep 22, 3:59 PM ET. Market closed.
$0.23 ▼ -0.01 (-2.62%)
After hours: Sep 22, 7:01 PM ET

Summary

Previous Close
$0.22
Open
$0.23
Day's Range
$0.22 – $0.24
52 Week Range
$0.17 – $2.65
Volume
313,195
Avg. Volume
713,479
Market Cap
$4.17M
Beta (5Y Monthly)
0.00
PE Ratio (TTM)
--
EPS (TTM)
-$0.45
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Hillstream BioPharma, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
1
CEO
Randy D. Milby MBA

Hillstream BioPharma, Inc. is a pre-clinical stage biotechnology firm committed to creating groundbreaking therapeutic options. Its core mission is to exploit ferroptosis, an anti-cancer pathway that initiates iron-mediated cell death (IMCD), specifically to address cancers that are resistant to conventional treatments. The company's developmental pipeline features several key candidates: HSB-1216: An IMCD inducer currently under development for solid tumor indications.

Earnings

DateEst.Actual
Nov 13, 2023-$0.05-$0.11Miss
Aug 11, 2023$0.16$0.16Beat
May 22, 2023$0.11$0.23Beat
Mar 16, 2023–$0.15
Nov 14, 2022–$0.18
Aug 10, 2022–-$0.14

Analyst view

Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on HILS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.